跳至主要内容
临床试验/IRCT201212121556N49
IRCT201212121556N49已完成2 期

comparing the efficacy of methotrexate and laparoscopic salpingostomy in treating patients with ectopic pregnancy and their role in fallopian tubes patency

Vice Chancellor for Research, Tehran University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 40 years(—)
性别
Female

入选标准

  • inclusion criteria:
  • 1- hemodynamic stability
  • 2- ectopic mass size below 4 cm
  • 3- patients' commitment for complete treatment and follow up
  • 4- absence of MTX treatment contraindication
  • Exclusion criteria:
  • 1- breast feeding
  • 2- immune deficiency
  • 3- abnormalities in hematologic system including anemia, locopenia, thrombocytopenia
  • 4- known hypersensivity reaction to MTX
  • 5- acute respiratory disease
  • 6- acute peptic ulcer
  • 7- alcoholism
  • 8- clinical malfunction of liver and kidney
  • 9- evidence of acute intraabdominal bleeding
  • 10- evidence of cardiac function in the embryo
  • 11- clinical sign and symptom of ectopic pregnancy, or B-hCG level below 5000 IU/L (with mild sign and symptoms)

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research, Tehran University of Medical Sciences

相似试验